Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27827978 | 0.79 | ANPEP (0.33) | ANPEP | |
| SCHEMBL23296192 | 0.77 | KDM4E (0.36) | — | |
| SCHEMBL30107911 | 0.74 | TP53 (0.36) | — | |
| SCHEMBL27084477 | 0.70 | ANPEP (0.38) | ANPEP | |
| SCHEMBL28855634 | 0.68 | TP53 (0.48) | — | |
| SCHEMBL12570457 | 0.67 | — | — | |
| Sulfuric Acid SCHEMBL31326240 | 0.67 | KISS1R (0.36) | ANPEP | |
| SCHEMBL7464312 | 0.67 | TDP1 (0.57) | — | |
| Sulfuric Acid SCHEMBL10528253 | 0.67 | TDP1 (0.57) | — | |
| SCHEMBL23451648 | 0.66 | TDP1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190315699-A1 | SELECTIVE SULFONATION OF BENZODIAZEPINE DERIVATIVES | IMMUNOGEN, INC. | 2019-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190315699-A1 | SELECTIVE SULFONATION OF BENZODIAZEPINE DERIVATIVES | GABRA2, GABRA4, GABRA1 | ANPEP 1496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.